Search results for "Cardiovascular Mortality"

showing 10 items of 39 documents

Mediterranean Diet and Gene-Mediterranean Diet Interactions in Determining Intermediate Cardiovascular Disease Phenotypes

2012

According to European statistics, 2008 for CVD, the leading causes of death in Europe are coronary heart disease and stroke. In Europe, deaths from these diseases are 4.3 million each year. Nearly half (48%) of all deaths are due to CVD (54% of deaths in women and 43% of deaths in men). Regional variations in cardiovascular mortality have been observed both between and within countries in Europe (Sans et al., 1997; Muller et al., 2004). Coronary heart disease mortality patterns showed a clear north–east to south–west gradient in CVD mortality (1990–1992; 45–74 years age-adjusted) with the lowest rates for both men and women in France, Spain, Switzerland, and Italy (Sans et al., 1997). Many …

Mediterranean dietLife stylebusiness.industrymedicinemedicine.diseaseEating behaviourCvd mortalitybusinessClinical phenotypeStrokeCoronary heart diseaseDemographyCardiovascular mortality
researchProduct

Short term associations of ambient nitrogen dioxide with daily total, cardiovascular, and respiratory mortality: multilocation analysis in 398 cities

2021

Objective To evaluate the short term associations between nitrogen dioxide (NO2) and total, cardiovascular, and respiratory mortality across multiple countries/regions worldwide, using a uniform analytical protocol. Design Two stage, time series approach, with overdispersed generalised linear models and multilevel meta-analysis. Setting 398 cities in 22 low to high income countries/regions. Main outcome measures Daily deaths from total (62.8 million), cardiovascular (19.7 million), and respiratory (5.5 million) causes between 1973 and 2018. Results On average, a 10 μg/m3 increase in NO2 concentration on lag 1 day (previous day) was associated with 0.46% (95% confidence interval 0.36% to 0.5…

OzoneNitrogen DioxideRespiratory Tract Diseases610 Medicine & healthAir Pollutants; Air Pollution; Cardiovascular Diseases; Cities; Developed Countries; Developing Countries; Environmental Exposure; Global Health; Humans; Linear Models; Nitrogen Dioxide; Respiratory Tract Diseases; Urban HealthRespiratory MortalityHealth benefitsGlobal HealthArbetsmedicin och miljömedicinchemistry.chemical_compound360 Social problems & social servicesCardiovascular MortalityAir PollutionHumansMedicineAmbient Nitrogen DioxideNitrogen dioxideCitiesRespiratory system610 Medicine & healthDeveloping CountriesMCCAir Pollutantsbusiness.industryResearchDeveloped CountriesUrban HealthEnvironmental ExposureOccupational Health and Environmental HealthGeneral MedicineEnvironmental exposureConfidence intervalTerm (time)Increased riskchemistryambient nitrogen dioxideCardiovascular DiseasesLinear ModelsRespiratory mortalityDeterminantes da Saúde e da Doençabusiness360 Social problems & social servicesDaily MortalityDemography
researchProduct

Mortality risk attributable to wildfire-related PM2·5 pollution: a global time series study in 749 locations

2021

Summary Background Many regions of the world are now facing more frequent and unprecedentedly large wildfires. However, the association between wildfire-related PM2·5 and mortality has not been well characterised. We aimed to comprehensively assess the association between short-term exposure to wildfire-related PM2·5 and mortality across various regions of the world. Methods For this time series study, data on daily counts of deaths for all causes, cardiovascular causes, and respiratory causes were collected from 749 cities in 43 countries and regions during 2000–16. Daily concentrations of wildfire-related PM2·5 were estimated using the three-dimensional chemical transport model GEOS-Chem …

PollutionHealth (social science)all cause mortalitymedia_common.quotation_subjectPopulationMedicine (miscellaneous)610 Medicine & healthPM2.5medical researchwildfirehealth hazard360 Social problems & social servicescardiovascular mortalityEnvironmental healthMedicinecontrolled studyhumaneducation610 Medicine & healthMortality riskCardiovascular mortalitymedia_commonSeries (stratigraphy)education.field_of_studybusiness.industryHealth Policypublic healthPublic Health Environmental and Occupational Healtharticlerisk assessmentPublic Health Global Health Social Medicine and Epidemiologyshort term exposurePollutionFolkhälsovetenskap global hälsa socialmedicin och epidemiologiIncreased riskrisk factorcityRelative risktime series analysisAttributable riskPM 2·5 Pollutionmortality riskDeterminantes da Saúde e da DoençaGenotoxicidade Ambientalbusiness360 Social problems & social servicesGlobal timemeta analysis
researchProduct

Endurance training: Is it bad for you?

2016

Educational aims To illustrate the characteristics of endurance exercise training and its positive effects on health. To provide an overview on the effects of endurance training on airway cells and bronchial reactivity. To summarise the current knowledge on respiratory health problems in elite athletes. Endurance exercise training exerts many positive effects on health, including improved metabol­ism, reduction of cardiovascular risk, and reduced all-cause and cardiovascular mortality. Intense endurance exercise causes mild epithelial injury and inflammation in the airways, but does not appear to exert detrimental effects on respiratory health or bronchial reactivity in recreational/non-eli…

Pulmonary and Respiratory Medicinemedicine.medical_specialty2ReviewsSettore MED/10 - Malattie Dell'Apparato RespiratorioSettore BIO/09 - Fisiologia03 medical and health sciences0302 clinical medicineEndurance trainingmedicineElite athletesRespiratory healthAsthmaCardiovascular mortalitylcsh:RC705-779biologyAthletesbusiness.industryHigh intensity030229 sport scienceslcsh:Diseases of the respiratory systemmedicine.diseasebiology.organism_classification12030228 respiratory systemPhysical therapyairway cells bronchial reactivity training elite athletes sports asthmabusiness
researchProduct

Cardiovascular effects of air pollution

2017

Air pollution is composed of particulate matter (PM) and gaseous pollutants, such as nitrogen dioxide and ozone. PM is classified according to size into coarse particles (PM 10), fine particles (PM 2.5) and ultrafine particles. We aim to provide an original review of the scientific evidence from epidemiological and experimental studies examining the cardiovascular effects of outdoor air pollution. Pooled epidemiological studies reported that a 10 μg/m 3 increase in long-term exposure to PM 2.5 was associated with an 11% increase in cardiovascular mortality. Increased cardiovascular mortality was also related to long-term and short-term exposure to nitrogen dioxide. Exposure to air pollution…

Time FactorsCardiovascular mortalityOzoneair pollutionAir pollution030204 cardiovascular system & hematology010501 environmental sciencesmedicine.disease_causeCardiovascular SystemRisk Assessment01 natural sciencesArticleToxicology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsEnvironmental healthUltrafine particleAnimalsHumansoxidative stressMedicineNitrogen dioxidePlatelet activationBlood CoagulationAir quality index0105 earth and related environmental sciencesparticulate matterPollutantAir Pollutantsbusiness.industryEnvironmental ExposureGeneral MedicineParticulatesPrognosisPlaque Atheroscleroticmyocardial infarctionchemistryCardiovascular DiseasesReactive Oxygen SpeciesCardiology and Cardiovascular MedicinebusinessArchives of Cardiovascular Diseases
researchProduct

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Ass…

2017

International audience; : Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to pr…

cardiovascular riskRiskarterial hypertensionmedicine.medical_specialtyNoninvasive imagingPhysiologyPopulation030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicinetarget organ damageInternal medicineInternal MedicineHumansMedicineIn patient030212 general & internal medicineAdverse effectIntensive care medicineeducationSocieties MedicalCardiovascular mortalitySubclinical infectionCardiac Imaging Techniqueeducation.field_of_studybusiness.industrynoninvasive cardiovascular imagingTarget organ damage3. Good healthCardiac Imaging TechniquesHypertensionPractice Guidelines as TopicCardiology[SDV.IB]Life Sciences [q-bio]/Bioengineeringmedicine.symptomCardiology and Cardiovascular MedicinebusinessprognosiHuman
researchProduct

Critical limb ischaemia: definition and natural hystory

2004

The term critical limb ischemia refers to a condition characterized by chronic ischemic at-rest pain, ulcers, or gangrene in one or both legs attributable to objectively proven arterial occlusive disease. Critical limb ischemia implies chronicity and is to be distinguished from acute limb ischemia. Its incidence is approximately 500 to 1000 per million year, with the highest rates among older subjects, smokers and diabetics. The rate of primary amputation ranges from 10% to 40%, and was performed only when no graftable distal vessels were present, or in neurologically impaired or hopelessly nonambulatory patients. Contrarily, in some highly specialized and aggressive centres about 90% of pa…

critical limb ischemiamedicine.medical_specialtyArteriosclerosismedicine.medical_treatmentRevascularizationAmputation SurgicalGangrenearterial occlusive diseaseIschemiaRisk Factorscardiovascular mortalityInternal medicinePeripheral arterial diseaseMedicineHumansMyocardial infarctionStrokePharmacologyGangrenePeripheral Vascular DiseasesLegbusiness.industryFootcardiovascular morbiditysurgical revascularizationHematologyCritical limb ischemiamedicine.diseaseIntermittent claudicationFontaine’s classificationSurgerybody regionsNatural historyAmputationrisk factors amputationCardiologyMolecular Medicinemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Heart in Hyperthyroidism

2019

Hyperthyroidism is a common endocrine disorder that produces important clinical consequences on the cardiovascular system. In overt hyperthyroidism the increase in left ventricular performance is predominantly sustained by an increased preload with enhanced left ventricular diastolic function and reduced systemic vascular resistance. The pattern of cardiovascular abnormalities is similar in subclinical and overt hypothyroidism, suggesting that a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. Untreated overt and subclinical hypothyroidism can lead to an increased risk of coronary heart disease (CHD), heart failure (HF), and cardiovascular mortality.

endocrine systemmedicine.medical_specialtyendocrine system diseasesbusiness.industryThyroidmedicine.diseasePreloadmedicine.anatomical_structureHeart failureInternal medicineVascular resistanceCardiologyMedicineEndocrine systembusinesshormones hormone substitutes and hormone antagonistsCardiovascular mortalitySubclinical infectionHormone
researchProduct

0326: Prognostic factors and impact of blood pressure level during the first 48 hours after myocardial infarction

2016

Background High blood pressure and low blood pressure are perfectly identified cardio-vascular risk factors, especially in primary prevention. However, their respective role after myocardial infarction is uncertain, with few data available. Objectives To compare cardio-vascular deaths and events after myocardial infarction between the different blood pressure levels observed during the first forty-eight hours. Methods We carried out an observational, prospective, monocentric study, including all consecutive patients admitted in Dijon’s Cardiologic Intensive Care Unit for myocardial infarction, between February 2012 and February 2014. Systolic blood pressure (SBP) was defined as the average …

medicine.medical_specialtyAcute coronary syndromeEjection fractionbusiness.industryBlood pressure level[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPrognostic factorsmedicine.diseaseIntensive care unitlaw.inventionSurgeryMyocardial infarctionBlood pressurelawInternal medicineCardiologyMedicineObservational studycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicinebusinessComputingMilieux_MISCELLANEOUSCardiovascular mortalityArchives of Cardiovascular Diseases Supplements
researchProduct

Expert opinion on managing chronic HCV in patients with cardiovascular disease

2018

International audience; Extrahepatic manifestations of chronic HCV infection include cardiovascular diseases and an increase in cardiovascular mortality. The pathogenic mechanisms by which HCV contributes to cardiovascular disease are not well defined, however, it is likely that systemic inflammation, and the promotion of other metabolic diseases are involved. In this Review, the evidence for HCV infection as a non-traditional risk factor for cardiovascular disease is evaluated. Furthermore, practical advice to evaluate cardiovascular disease risk and disease in chronic hepatitis C patients are included for help in daily clinical practice. Despite the advances in therapies for the treatment…

medicine.medical_specialtyCardiotonic AgentsHepacivirusDisease030204 cardiovascular system & hematologySystemic inflammationAntiviral Agents03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesOdds RatioHumansMedicineDrug InteractionsPharmacology (medical)In patient030212 general & internal medicineRisk factorIntensive care medicineExpert TestimonyCardiovascular mortalityInflammationPharmacologybusiness.industryDisease progressionDisease ManagementHepatitis C Chronic3. Good healthInfectious DiseasesCardiovascular DiseasesExpert opinionPractice Guidelines as TopicDisease riskmedicine.symptombusiness
researchProduct